Eisen, T., Marais, R., Affolter, A., Lorigan, P., Robert, C., Corrie, P., . . . Gore, M. E. (2011). Sorafenib and dacarbazine as first-line therapy for advanced melanoma: Phase I and open-label phase II studies. Nature Publishing Group.
Citação norma ChicagoEisen, T., et al. Sorafenib and Dacarbazine As First-line Therapy for Advanced Melanoma: Phase I and Open-label Phase II Studies. Nature Publishing Group, 2011.
MLA CitationEisen, T., et al. Sorafenib and Dacarbazine As First-line Therapy for Advanced Melanoma: Phase I and Open-label Phase II Studies. Nature Publishing Group, 2011.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.